Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: The role of estrogen receptor α and c-Myc

Endocrine-Related Cancer

Volumn 16, Issue 3, 2009, Pages 819-834

  Dadiani, Maya ^a   Seger, Dalia ^a   Kreizman, Tamar ^a   Badikhi, Daria ^a   Margalit, Raanan ^a   Eilam, Raya ^a   Degani, Hadassa ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; FULVESTRANT; MYC PROTEIN; SMALL INTERFERING RNA; VASCULOTROPIN;

ARTICLE; BLOOD VESSEL PERMEABILITY; BREAST CANCER; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; TRANSCRIPTION INITIATION SITE; TUMOR VASCULARIZATION; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70549103505     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-08-0249     Document Type: Article

References (54)

1. Barr LF, Campbell SE, Diette GB, Gabrielson EW, Kim S, Shim H & Dang CV 2000 c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression. Cancer Research 60 143-149. (Pubitemid 30058744)
2. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN & Cleveland JL 2002 c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes and Development 16 2530-2543.
3. Bogin L & Degani H 2002 Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer. Cancer Research 62 1948-1951. (Pubitemid 34408435)
4. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J & Perrot-Applanat M 2002 Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Research 62 4977-4984. (Pubitemid 34984422)
5. Butt AJ, Caldon CE, McNeil CM, Swarbrick A, Musgrove EA & Sutherland RL 2008 Cell cycle machinery: links with genesis and treatment of breast cancer. Advances in Experimental Medicine and Biology 630 189-205.
6. Cheng AS, Jin VX, Fan M, Smith LT, Liyanarachchi S, Yan PS, Leu YW, Chan MW, Plass C, Nephew KP et al. 2006 Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Molecular Cell 21 393-404. (Pubitemid 43163534)
7. Cole MD & McMahon SB 1999 The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18 2916-2924. (Pubitemid 29276532)
8. Creighton CJ, Cordero KE, Larios JM, Miller RS, Johnson MD, Chinnaiyan AM, Lippman ME & Rae JM 2006 Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors. Genome Biology 7 R28.
9. Dang CV, Resar LM, Emison E, Kim S, Li Q, Prescott JE, Wonsey D & Zeller K 1999 Function of the c-Myc oncogenic transcription factor. Experimental Cell Research 253 63-77.
10. Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA & Sutherland RL 2003 Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocrine-Related Cancer 10 179-186. (Pubitemid 36758647)
11. Driscoll MD, Sathya G, Muyan M, Klinge CM, Hilf R & Bambara RA 1998 Sequence requirements for estrogen receptor binding to estrogen response elements. Journal of Biological Chemistry 273 29321-29330. (Pubitemid 28509931)
12. Dubik D & Shiu RP 1988 Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. Journal of Biological Chemistry 263 12705-12708. (Pubitemid 19000455)
13. Dubik D & Shiu RP 1992 Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7 1587-1594.
14. Dvorak HF 2002 Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. Journal of Clinical Oncology 20 4368-4380.
15. Evans SM, Koch CJ, Laughlin KM, Jenkins WT, Van Winkle T & Wilson DF 1997 Tamoxifen induces hypoxia in MCF-7 xenografts. Cancer Research 57 5155-5161. (Pubitemid 27498135)
16. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR & Katzenellenbogen BS 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144 4562-4574. (Pubitemid 37204856)
17. Furman-Haran E, Grobgeld D & Degani H 1997 Dynamic contrast-enhanced imaging and analysis at high spatial resolution of MCF7 human breast tumors. Journal of Magnetic Resonance 128 161-171. (Pubitemid 127452799)
18. Hartman J, Lindberg K, Morani A, Inzunza J, Strom A & Gustafsson JA 2006 Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Research 66 11207-11213. (Pubitemid 46009948)
19. Harvell DM, Richer JK, Allred DC, Sartorius CA & Horwitz KB 2006 Estradiol regulates different genes in human breast tumor xenografts compared with the identical cells in culture. Endocrinology 147 700-713 (Epub 2005 Oct 2020).
20. Hicklin DJ & Ellis LM 2005 Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. Journal of Clinical Oncology 23 1011-1027. (Pubitemid 46202320)
21. Hyder SM 2006 Sex-steroid regulation of vascular endothelial growth factor in breast cancer. Endocrine-Related Cancer 13 667-687. (Pubitemid 44763251)
22. Hyder SM, Nawaz Z, Chiappetta C & Stancel GM 2000 Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Research 60 3183-3190. (Pubitemid 30407915)
23. Jarvinen TA, Pelto-Huikko M, Holli K & Isola J 2000 Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. American Journal of Pathology 156 29-35. (Pubitemid 30644435)
24. Kawai H, Li H, Chun P, Avraham S & Avraham HK 2002 Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Oncogene 21 7730-7739. (Pubitemid 35398818)
25. Kazi AA, Jones JM & Koos RD 2005 Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Molecular Endocrinology 19 2006-2019.
26. Knies-Bamforth UE, Fox SB, Poulsom R, Evan GI & Harris AL 2004 c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism. Cancer Research 64 6563-6570. (Pubitemid 39297915)
27. Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S & Sonoo H 2000 Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Clinical Cancer Research 6 512-518. (Pubitemid 30111472)
28. Liao DJ & Dickson RB 2000 c-Myc in breast cancer. Endocrine-Related Cancer 7 143-164.
29. Long X & Nephew KP 2006 Fulvestrant (ICI 182,780)- dependent interacting proteins mediate immobilization and degradation of estrogen receptor-alpha. Journal of Biological Chemistry 281 9607-9615. (Pubitemid 43864679)
30. Loureiro RM & D'Amore PA 2005 Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine & Growth Factor Reviews 16 77-89. (Pubitemid 40279118)
31. Maity A, Sall W, Koch CJ, Oprysko PR & Evans SM 2001 Low pO2 and beta-estradiol induce VEGF in MCF-7 and MCF-7-5C cells: relationship to in vivo hypoxia. Breast Cancer Research and Treatment 67 51-60. (Pubitemid 32703388)
32. McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD & Cole MD 1998 The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94 363-374.
33. Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC & Taylor RN 2000 Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. PNAS 97 10972-10977. (Pubitemid 30751263)
34. Musgrove EA, Sergio CM, Loi S, Inman CK, Anderson LR, Alles MC, Pinese M, Caldon CE, Schutte J, Gardiner-Garden M et al. 2008 Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer. PLoS ONE 3 e2987.
35. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M & Gustafsson JA 2001 Mechanisms of estrogen action. Physiological Reviews 81 1535-1565.
36. Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Warri A, Weihua Z, Van Noorden S, Wahlstrom T, Coombes RC, Warner M et al. 2002 Estrogen receptor beta in breast cancer. Endocrine-Related Cancer 9 1-13. (Pubitemid 34302928)
37. Pelengaris S, Khan M & Evan G 2002 c-MYC: more than just a matter of life and death. Nature Reviews. Cancer 2 764-776. (Pubitemid 37328911)
38. Prall OW, Rogan EM, Musgrove EA, Watts CK & Sutherland RL 1998 c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Molecular and Cellular Biology 18 4499-4508.
39. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J & Gannon F 2003 Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Molecular Cell 11 695-707. (Pubitemid 36385123)
40. Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K & Harkonen PL 1999 Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Molecular Endocrinology 149 29-40. (Pubitemid 29236221)
41. Safe S & Kim K 2004 Nuclear receptor-mediated transactivation through interaction with Sp proteins. Progress in Nucleic Acid Research and Molecular Biology 77 1-36.
42. Scott PA, Gleadle JM, Bicknell R & Harris AL 1998 Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. International Journal of Cancer 75 706-712. (Pubitemid 28145817)
43. Shang Y, Hu X, DiRenzo J, Lazar MA & Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103 843-852.
44. Shaw LE, Sadler AJ, Pugazhendhi D & Darbre PD 2006 Changes in oestrogen receptor-alpha and -beta during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 99 19-32.
45. Shchors K, Shchors E, Rostker F, Lawlor ER, Brown-Swigart L & Evan GI 2006 The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta. Genes and Development 20 2527-2538. (Pubitemid 44396838)
46. Stoner M, Saville B, Wormke M, Dean D, Burghardt R & Safe S 2002 Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. Molecular Endocrinology 16 2231-2242. (Pubitemid 35155536)
47. Stoner M, Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M & Safe S 2004 Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Oncogene 23 1052-1063. (Pubitemid 38269959)
48. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J & Gustafsson JA 2004 Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. PNAS 101 1566-1571. (Pubitemid 38236167)
49. Takei H, Lee ES & Jordan VC 2002 In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer. Breast Cancer 9 39-42.
50. Tofts PS 1997 Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. Journal of Magnetic Resonance Imaging 7 91-101.
51. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ et al. 1999 Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. Journal of Magnetic Resonance Imaging 10 223-232. (Pubitemid 29463104)
52. Venditti M, Iwasiow B, Orr FW & Shiu RP 2002 C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells. International Journal of Cancer 99 35-42. (Pubitemid 34273195)
53. Williams C, Edvardsson K, Lewandowski SA, Ström A & Gustafsson JA 2008 A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene 27 1019-1032. (Pubitemid 351225390)
54. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ & Holash J 2000 Vascular-specific growth factors and blood vessel formation. Nature 407 242-248.